Francisco Burillo Gómez

Francisco Burillo Gómez

Auto-generated profile, based on publicly available information

Francisco Burillo Gómez

Cardiology Department, Hospital Universitario San Cecilio . Av. del Conocimiento, s/n, Granada 18016

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2026 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
DSDiego Segura-Rodríguez
Diego Segura-Rodríguez
MMMiguel Morales-García
Miguel Morales-García
EEEDUARDO MORENO ESCOBAR
EDUARDO MORENO ESCOBAR
PFPilar Martín de la Fuente
Pilar Martín de la Fuente
FGFrancisco Burillo Gómez
Francisco Burillo Gómez
RGRocío García-Orta
Rocío García-Orta
Aims: Bicuspid aortic valve-associated aortopathy (BAVA) and heritable thoracic aortic disease (HTAD) share clinical manifestations but may represent distinct pathophysiological entities. We aimed to compare morphological and haemodynamic profiles between both groups using cardiovascular magnetic resonance (CMR) imaging and non-invasive systemic haemodynamic assessment. Methods and results: A total of 185 patients (111 BAVA, 74 HTAD) were prospectively enrolled. CMR 4D-flow assessed aortic distensibility (ADCMR), pulse wave velocity (PWVCMR), global wall shear stress (WSSCMR), and energy loss (ELCMR). Oscillometry assessed systemic PWVM, augmentation index (AIxM), and systemic vascular resistance (SVRM). Composite adverse aortic events (AAEs) comprised acute aortic syndrome, cardiovascular death, or guideline diameter-based indication for surgery over 42.1 ± 17.6 months. BAVA showed greater tubular ascending aorta and sinotubular junction dilation, ascending aorta WSSCMR (0.42 ± 0.18 vs. 0.28 ± 0.12 Pa, P = 0.020), ELCMR (19.8 ± 8.4 vs. 12.3 ± 6.1 mW, P < 0.001), and ADCMR (6.1 ± 3.5 vs. 4.8 ± 2.9 × 10⁻³ mmHg⁻¹, P = 0.023), yet lower systemic stiffness than HTAD (PWVM 6.2 ± 1.7 vs. 7.8 ± 2.1 m/s; AIxM 12.1 ± 7.6 vs. 18.4 ± 9.2%; both P < 0.001). AAE rates were similar. In exploratory aetiology-specific analyses, ascending aorta WSSCMR was associated with events in BAVA (HR 8.92, 95% CI 2.85–27.95) and systemic PWVM in HTAD (HR 2.16, 95% CI 1.30–3.57). Conclusion: BAVA and HTAD show distinct morphological and haemodynamic phenotypes: BAVA with focal dilation, elevated WSSCMR/ELCMR and preserved systemic function; HTAD with reduced local distensibility and greater systemic stiffness. These aetiology-specific predictors are exploratory and require external validation.